Novel molecular markers and immune regulatory pathways are uncovered, providing insight into MM prognosis and possible therapeutic strategies, using integrated bioinformatics, machine learning, and experimental approaches.
Wen-Jing Li, Li Li, Yu Sun et al.· American journal of translat...· 0 citations
Bone-marrow-based gene methylation markers may act as candidate epigenetic biomarkers for risk stratification in DLBCL, but results cannot yet support direct clinical judgement for hematopoietic stem cell transplantation.
Tian-Hua Zhao, Jing-Jing Liu, L. Geng et al.· Leukemia research : a Forum...· 0 citations
Positioning circRNAs as multimodal regulatory hubs, this review provides a theoretical framework for developing circRNA-based immunotherapies to overcome resistance in lymphoma.
Jingjing Liu, Tianhua Zhao, Yan-Ning Wu et al.· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.